<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmoniq.com/news/ftc-lawsuit-prescription-drug-benefit-managers-antitrust</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-09T14:10:49.590Z</news:publication_date>
      <news:title>FTC Files Antitrust Lawsuit Against Nation&apos;s Three Largest PBMs</news:title>
      <news:keywords>PBM, drug-pricing, antitrust, FTC, healthcare-regulation</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/fda-bars-nmn-supplements-drug-exclusion-clause</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-09T08:47:03.024Z</news:publication_date>
      <news:title>FDA Bars NMN Supplements After Pharma Invokes Drug Exclusion Clause</news:title>
      <news:keywords>NMN, drug-exclusion-clause, FDA-regulation, dietary-supplements, NAD-precursors</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/daraxonrasib-pancreatic-cancer-trial-results-2024</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-08T14:10:49.985Z</news:publication_date>
      <news:title>Daraxonrasib Shows 60% Mortality Reduction in Pancreatic Cancer Trials</news:title>
      <news:keywords>pancreatic cancer, daraxonrasib, KRAS inhibitor, clinical trials, oncology</news:keywords>
    </news:news>
  </url>
</urlset>